By the time most people receive a diagnosis of Alzheimer's disease—based on clinical signs of mental decline—their brains have already suffered a decade or more of damage. But although the mechanisms that spur the destruction ...
Mar 23, 2015
0
15
They identified blood-based biological markers that are associated with the build up of a toxic protein in the brain which occurs years before symptoms appear and irreversible brain damage has occurred.
May 1, 2013
0
0
Researchers at the University of Rochester Medical Center (URMC) have discovered a potentially new approach to deliver therapeutics more effectively to the brain. The research could have implications for the treatment of ...
Oct 18, 2018
0
1
Researchers have shown that the levels of two proteins present in blood and cerebrospinal fluid increase significantly at different time points following traumatic brain injury (TBI), confirming their potential value as biomarkers ...
Jul 21, 2015
0
39
People in middle age who have a high blood pressure measure called pulse pressure are more likely to have biomarkers of Alzheimer's disease in their spinal fluid than those with lower pulse pressure, according to research ...
Nov 13, 2013
0
0
New research published in Nature Communications from scientists at Huntsman Cancer Institute (HCI) at the University of Utah (U of U), in collaboration with the Stanford University School of Medicine, shows a specific protein ...
Oct 11, 2018
0
0
Cerebral spinal fluid (CSF) levels of β-amyloid 42(Aβ42) are associated with the diagnosis of Alzheimer's disease (AD) and (Aβ) accumulation in the brain independent of apolipoprotein E (APOE) gene makeup.
Aug 27, 2014
0
0
Researchers at University of Michigan have developed a method to produce artificially grown miniature brains—called human brain organoids—free of animal cells that could greatly improve the way neurodegenerative conditions ...
Jul 13, 2023
0
33
A study published today reported the identification of what may be the earliest known biomarker associated with the risk of developing Alzheimer's disease (AD). The results suggest that this novel potential biomarker is present ...
Aug 14, 2013
0
0
Researchers at Duke University conducted a randomized clinical trial in patients with subarachnoid hemorrhage (SAH). In this study, the researchers compared two approaches to intracranial pressure management—continuous ...
Aug 20, 2013
0
0
